{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:25:47Z","timestamp":1791890747539,"version":"4.3.4"},"reference-count":285,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.autrev.2011.11.026","type":"journal-article","created":{"date-parts":[[2011,12,12]],"date-time":"2011-12-12T10:30:10Z","timestamp":1323685810000},"page":"687-698","source":"Crossref","is-referenced-by-count":264,"title":["New insights into the pathogenesis of Beh\u00e7et's disease"],"prefix":"10.1016","volume":"11","author":[{"given":"Marc","family":"Pineton de Chambrun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Wechsler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Geri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Cacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Saadoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2011.11.026_bb0005","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ng.625","article-title":"Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease","volume":"42","author":"Remmers","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2011.11.026_bb0010","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ng.624","article-title":"Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet's disease susceptibility loci","volume":"42","author":"Mizuki","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2011.11.026_bb0015","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jaci.2011.05.029","article-title":"Critical role of IL-21 in modulating T(H)17 and regulatory T cells in Behcet disease","volume":"128","author":"Geri","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0020","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","article-title":"Behcet's disease","volume":"341","author":"Sakane","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2011.11.026_bb0025","first-page":"471","article-title":"Benediktos Adamantiades and his forgotten contributions to medicine","volume":"12","author":"Zouboulis","year":"2002","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0030","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1136\/bjo.87.9.1175","article-title":"Behcet's disease: from Hippocrates to the third millennium","volume":"87","author":"Verity","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0035","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1034\/j.1399-0039.1999.540301.x","article-title":"Behcet's disease, the Silk Road and HLA-B51: historical and geographical perspectives","volume":"54","author":"Verity","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.autrev.2011.11.026_bb0040","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1371\/journal.pmed.0030297","article-title":"A proposed classification of the immunological diseases","volume":"3","author":"McGonagle","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.autrev.2011.11.026_bb0045","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/art.24642","article-title":"HLA-B51\/B5 and the risk of Behcet's disease: a systematic review and meta-analysis of case-control genetic association studies","volume":"61","author":"de Menthon","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.11.026_bb0050","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.autrev.2009.10.005","article-title":"Etiopathogenesis of Behcet's disease","volume":"9","author":"Mendoza-Pinto","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.11.026_bb0055","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/ar2757","article-title":"Novel genetic analysis in Behcet's disease","volume":"11","author":"Wallace","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2011.11.026_bb0060","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/ard.2009.108571","article-title":"Genetics of Behcet disease inside and outside the MHC","volume":"69","author":"Meguro","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.11.026_bb0065","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/archopht.1982.01030040433013","article-title":"Close association of HLA-Bw51 with Behcet's disease","volume":"100","author":"Ohno","year":"1982","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0070","doi-asserted-by":"crossref","first-page":"R66","DOI":"10.1186\/ar2695","article-title":"Identification of novel genetic susceptibility loci for Behcet's disease using a genome-wide association study","volume":"11","author":"Fei","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2011.11.026_bb0075","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/44853","article-title":"The MHC sequencing consortium","volume":"401","author":"Complete sequence and gene map of a human major histocompatibility complex","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2011.11.026_bb0080","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1423-0410.2010.01438.x","article-title":"HLA, immunogenetics, pharmacogenetics and personalized medicine","volume":"100","author":"Charron","year":"2011","journal-title":"Vox Sang"},{"key":"10.1016\/j.autrev.2011.11.026_bb0085","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1034\/j.1399-0039.2002.600506.x","article-title":"Analysis of microsatellite polymorphism around the HLA-B locus in Iranian patients with Behcet's disease","volume":"60","author":"Mizuki","year":"2002","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.autrev.2011.11.026_bb0090","first-page":"1921","article-title":"Association of MICA gene and HLA-B*5101 with Behcet's disease in Greece","volume":"40","author":"Yabuki","year":"1999","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2011.11.026_bb0095","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3346\/jkms.2002.17.3.366","article-title":"Association of MICA polymorphism with HLA-B51 and disease severity in Korean patients with Behcet's disease","volume":"17","author":"Park","year":"2002","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.autrev.2011.11.026_bb0100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/rheumatology\/keq331","article-title":"Genetic susceptibility to Behcet's disease: role of genes belonging to the MHC region","volume":"50","author":"Piga","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2011.11.026_bb0105","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1399-0039.2004.00280.x","article-title":"HLA class I and class II genotyping in patients with Behcet's disease: a regional study of eastern part of Turkey","volume":"64","author":"Pirim","year":"2004","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.autrev.2011.11.026_bb0110","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1034\/j.1399-0039.1999.540308.x","article-title":"HLA class I and II typing of the patients with Behcet's disease in Saudi Arabia","volume":"54","author":"Yabuki","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.autrev.2011.11.026_bb0115","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1034\/j.1399-0039.2001.057005457.x","article-title":"HLA class I genotyping including HLA-B*51 allele typing in the Iranian patients with Behcet's disease","volume":"57","author":"Mizuki","year":"2001","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.autrev.2011.11.026_bb0120","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1034\/j.1399-0039.2001.580306.x","article-title":"HLA-B*51 allele analysis by the PCR-SBT method and a strong association of HLA-B*5101 with Japanese patients with Behcet's disease","volume":"58","author":"Mizuki","year":"2001","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.autrev.2011.11.026_bb0125","first-page":"3332","article-title":"Human leukocyte antigen serologic and DNA typing of Behcet's disease and its primary association with B51","volume":"33","author":"Mizuki","year":"1992","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2011.11.026_bb0130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/0-306-48382-3_44","article-title":"MICA transmembrane region polymorphism and HLA B51 in Tunisian Behcet's disease patients","volume":"528","author":"Ben Ahmed","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0135","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3349\/ymj.1997.38.6.333","article-title":"Molecular genetics (HLA) of Behcet's disease","volume":"38","author":"Mizuki","year":"1997","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.autrev.2011.11.026_bb0140","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1399-0039.2008.01111.x","article-title":"Re-evaluation of heterogeneity in HLA-B*510101 associated with Behcet's disease","volume":"72","author":"Takemoto","year":"2008","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.autrev.2011.11.026_bb0145","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1034\/j.1399-0039.2002.590207.x","article-title":"Sequencing-based typing of HLA-B*51 alleles and the significant association of HLA-B*5101 and -B*5108 with Behcet's disease in Greek patients","volume":"59","author":"Mizuki","year":"2002","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.autrev.2011.11.026_bb0150","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1034\/j.1399-0039.1999.540605.x","article-title":"Significant associations of HLA-B*5101 and B*5108, and lack of association of class II alleles with Behcet's disease in Italian patients","volume":"54","author":"Kera","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.autrev.2011.11.026_bb0155","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/1529-0131(199909)42:9<1961::AID-ANR23>3.0.CO;2-7","article-title":"Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behcet's disease","volume":"42","author":"Mizuki","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.11.026_bb0160","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10384-007-0473-y","article-title":"Association of major histocompatibility complex class I chain-related gene A and HLA-B alleles with Behcet's disease in Turkey","volume":"51","author":"Mizuki","year":"2007","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0165","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1399-0039.2005.00465.x","article-title":"Associations of major histocompatibility complex class I chain-related molecule polymorphisms with Behcet's disease in Caucasian patients","volume":"66","author":"Hughes","year":"2005","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.autrev.2011.11.026_bb0170","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s002510050656","article-title":"MIC-A allele profiles and HLA class I associations in Behcet's disease","volume":"49","author":"Wallace","year":"1999","journal-title":"Immunogenetics"},{"key":"10.1016\/j.autrev.2011.11.026_bb0175","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/0-306-48382-3_43","article-title":"Strong association of MIC-A*009 of extracellular domains and MIC-A*A6 of transmembrane domain in Korean patients with Behcet's disease","volume":"528","author":"Mok","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0180","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1007\/s11033-010-0015-4","article-title":"Analyses of functional IL10 and TNF-alpha genotypes in Behcet's syndrome","volume":"37","author":"Ates","year":"2010","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.autrev.2011.11.026_bb0185","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/art.20873","article-title":"Association of the R92Q TNFRSF1A mutation and extracranial deep vein thrombosis in patients with Behcet's disease","volume":"52","author":"Amoura","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.11.026_bb0190","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3346\/jkms.2006.21.4.596","article-title":"Association of TNFA promoter region haplotype in Behcet's Disease","volume":"21","author":"Park","year":"2006","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.autrev.2011.11.026_bb0195","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/03009740601154244","article-title":"The novel -G646A polymorphism of the TNFalpha promoter is associated with the HLA-B51 allele in Korean patients with Behcet's disease","volume":"36","author":"Chang","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0200","first-page":"S130","article-title":"TNF polymorphisms in Lebanese patients with Behcet's disease","volume":"26","author":"Arayssi","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0205","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1365-2133.2006.07348.x","article-title":"TNF-alpha gene 1031 T\/C polymorphism in Turkish patients with Behcet's disease","volume":"155","author":"Akman","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0210","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00296-009-1134-x","article-title":"TNF-alpha gene polymorphisms in Iranian Azeri Turkish patients with Behcet's disease","volume":"30","author":"Bonyadi","year":"2009","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2011.11.026_bb0215","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.arcmed.2010.02.002","article-title":"TNF polymorphisms in patients with Behcet disease: a meta-analysis","volume":"41","author":"Touma","year":"2010","journal-title":"Arch Med Res"},{"key":"10.1016\/j.autrev.2011.11.026_bb0220","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1002\/1529-0131(200111)44:11<2693::AID-ART449>3.0.CO;2-M","article-title":"Linkage mapping of a novel susceptibility locus for Behcet's disease to chromosome 6p22-23","volume":"44","author":"Gul","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.11.026_bb0225","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1034\/j.1399-0039.2003.610110.x","article-title":"HLA-B phenotype modifies the course of Behcet's disease in Moroccan patients","volume":"61","author":"Choukri","year":"2003","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.autrev.2011.11.026_bb0230","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1399-0039.2008.01087.x","article-title":"New insights of HLA class I association to Behcet's disease in Portuguese patients","volume":"72","author":"Bettencourt","year":"2008","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.autrev.2011.11.026_bb0235","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/sj.gene.6363863","article-title":"A weak association of HLA-B*2702 with Behcet's disease","volume":"3","author":"Gul","year":"2002","journal-title":"Genes Immun"},{"key":"10.1016\/j.autrev.2011.11.026_bb0240","first-page":"419","article-title":"HLA-B*27 allele associated to Behcet's disease and to anterior uveitis in Moroccan patients","volume":"69","author":"Radouane","year":"2011","journal-title":"Ann Biol Clin (Paris)"},{"key":"10.1016\/j.autrev.2011.11.026_bb0245","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.humimm.2006.11.010","article-title":"IL-10 genotype analysis in patients with Behcet's disease","volume":"68","author":"Wallace","year":"2007","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0250","first-page":"S73","article-title":"Cytokine gene polymorphisms in Behcet's disease and their association with clinical and laboratory findings","volume":"27","author":"Dilek","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0255","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.4049\/jimmunol.168.11.5699","article-title":"A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R","volume":"168","author":"Parham","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0260","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1167\/iovs.07-1390","article-title":"Upregulated IL-23 and IL-17 in Behcet patients with active uveitis","volume":"49","author":"Chi","year":"2008","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2011.11.026_bb0265","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1136\/ard.2009.119420","article-title":"IL-23R gene confers susceptibility to Behcet's disease in a Chinese Han population","volume":"69","author":"Jiang","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.11.026_bb0270","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/rheumatology\/kel329","article-title":"Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder?","volume":"45","author":"Direskeneli","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2011.11.026_bb0275","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1568010053622894","article-title":"Behcet's disease as an autoinflammatory disorder","volume":"4","author":"Gul","year":"2005","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"10.1016\/j.autrev.2011.11.026_bb0280","first-page":"S35","article-title":"MEFV mutations are increased in Behcet's disease (BD) and are associated with vascular involvement","volume":"21","author":"Atagunduz","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0285","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/03009740801998788","article-title":"Molecular analysis of MEFV gene mutations among Palestinian patients with Behcet's disease","volume":"37","author":"Ayesh","year":"2008","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0290","doi-asserted-by":"crossref","first-page":"41783","DOI":"10.1155\/MI\/2006\/41783","article-title":"Genetic analysis of MEFV gene pyrin domain in patients with Behcet's disease","volume":"2006","author":"Dursun","year":"2006","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.autrev.2011.11.026_bb0295","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/03009740510017931","article-title":"MEFV gene is a probable susceptibility gene for Behcet's disease","volume":"34","author":"Imirzalioglu","year":"2005","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0300","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.0906-6705.2005.00253.x","article-title":"Specific interleukin-1 gene polymorphisms in Turkish patients with Behcet's disease","volume":"14","author":"Coskun","year":"2005","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0305","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3899\/jrheum.101202","article-title":"IL18 polymorphism is associated with Behcet's disease but not lupus in patients from Turkey","volume":"38","author":"Htoon","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0310","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00296-008-0664-y","article-title":"Interleukin-17F gene polymorphisms in Korean patients with Behcet's disease","volume":"29","author":"Jang","year":"2008","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2011.11.026_bb0315","first-page":"S59","article-title":"Interleukin-18 gene polymorphisms in Korean patients with Behcet's disease","volume":"23","author":"Jang","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0320","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/rheumatology\/keg232R","article-title":"Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behcet's disease","volume":"42","author":"Karasneh","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2011.11.026_bb0325","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.humimm.2006.07.012","article-title":"Interleukin-18 promoter polymorphisms in patients with Behcet's disease","volume":"67","author":"Lee","year":"2006","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0330","first-page":"S91","article-title":"Association of chemokine receptor 5 (CCR5) delta32 mutation with Behcet's disease is dependent on gender in Iranian patients","volume":"24","author":"Mojtahedi","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0335","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2230.2006.02212.x","article-title":"Toll-like receptor 2 Arg753Gln gene polymorphism in Turkish patients with Behcet's disease","volume":"31","author":"Bacanli","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0340","first-page":"S58","article-title":"Toll-like-receptor gene polymorphisms in a Tunisian population with Behcet's disease","volume":"27","author":"Ben Dhifallah","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0345","first-page":"S43","article-title":"Toll-like receptor 4 (TLR4) gene polymorphisms in Italian patients with Behcet's disease","volume":"27","author":"Boiardi","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0350","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s10067-009-1252-6","article-title":"No association of the TLR2 gene Arg753Gln polymorphism with rheumatic heart disease and Behcet's disease","volume":"28","author":"Cosan","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0355","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/rheumatology\/kep077","article-title":"Association of TLR4 polymorphisms with Behcet's disease in a Korean population","volume":"48","author":"Horie","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2011.11.026_bb0360","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1399-0039.2007.00924.x","article-title":"Lack of association of Toll-like receptor 9 gene polymorphism with Behcet's disease in Japanese patients","volume":"70","author":"Ito","year":"2007","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.autrev.2011.11.026_bb0365","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.humimm.2010.12.007","article-title":"Association analysis of Toll-like receptor 7 gene polymorphisms and Behcet's disease in Japanese patients","volume":"72","author":"Sada","year":"2011","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0370","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.humimm.2008.10.014","article-title":"Investigation of the association between Toll-like receptor 2 gene polymorphisms and Behcet's disease in Japanese patients","volume":"70","author":"Tomiyama","year":"2009","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0375","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.humimm.2007.06.002","article-title":"Associations between interferon regulatory factor-1 polymorphisms and Behcet's disease","volume":"68","author":"Lee","year":"2007","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0380","first-page":"2018","article-title":"Lack of association of two polymorphisms of IRF5 with Behcet's disease","volume":"15","author":"Li","year":"2009","journal-title":"Mol Vis"},{"key":"10.1016\/j.autrev.2011.11.026_bb0385","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-0039.2008.01186.x","article-title":"CTLA-4 +49A\/G polymorphism is associated with Behcet's disease in a Tunisian population","volume":"73","author":"Ben Dhifallah","year":"2009","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.autrev.2011.11.026_bb0390","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1136\/bjo.2008.156919","article-title":"No association of CTLA-4 polymorphisms with susceptibility to Behcet disease","volume":"93","author":"Du","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0395","unstructured":"Duzgun N, Duman T, Keskin O, Morris Y, Tutkak H. Cytotoxic T lymphocyte antigen-4 (CTLA-4) polymorphism in patients with Behcet's disease. Clin Exp Rheumatol.28:S100."},{"key":"10.1016\/j.autrev.2011.11.026_bb0400","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1744-313X.2007.00655.x","article-title":"Analysis of CD28 and CTLA-4 gene polymorphisms in Turkish patients with Behcet's disease","volume":"34","author":"Gunesacar","year":"2007","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.autrev.2011.11.026_bb0405","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1399-0039.2009.01303.x","article-title":"CTLA4 gene polymorphisms and soluble CTLA4 protein in Behcet's disease","volume":"74","author":"Park","year":"2009","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.autrev.2011.11.026_bb0410","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1365-2230.2005.01846.x","article-title":"CTLA-4 gene 49A\/G polymorphism in Turkish patients with Behcet's disease","volume":"30","author":"Sallakci","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0415","first-page":"S132","article-title":"CTLA-4 gene variants are not associated with Behcet's disease or its clinical manifestations","volume":"26","author":"Touma","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0420","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2230.2008.02786.x","article-title":"The functional role of nuclear factor kappa-kappaB1\u201394 ins\/del ATTG promotor gene polymorphism in Behcet's disease: an exploratory study","volume":"33","author":"Yalcin","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0425","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1399-0004.2010.01432.x","article-title":"NEMO mutation as a cause of familial occurrence of Behcet's disease in female patients","volume":"78","author":"Takada","year":"2010","journal-title":"Clin Genet"},{"key":"10.1016\/j.autrev.2011.11.026_bb0430","first-page":"1934","article-title":"Association between K469E polymorphism of intracellular adhesion molecules-1 ICAM-1 and Behcet's disease","volume":"27","author":"Saadat","year":"2006","journal-title":"Saudi Med J"},{"key":"10.1016\/j.autrev.2011.11.026_bb0435","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1365-2370.2000.00202.x","article-title":"Intercellular adhesion molecule-1 gene polymorphisms in Behcet's disease","volume":"27","author":"Verity","year":"2000","journal-title":"Eur J Immunogenet"},{"key":"10.1016\/j.autrev.2011.11.026_bb0440","first-page":"1283","article-title":"Intercellular adhesion molecule-1 gene polymorphisms in Behcet's Disease","volume":"28","author":"Boiardi","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0445","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3346\/jkms.2003.18.3.415","article-title":"Intercellular adhesion molecule-1 polymorphisms in Korean patients with Behcet\u2019s disease","volume":"18","author":"Kim","year":"2003","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.autrev.2011.11.026_bb0450","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1399-0039.2009.01395.x","article-title":"Intercellular adhesion molecule 1 K469E gene polymorphism is associated with presence of skin lesions in Tunisian Behcet's disease patients","volume":"75","author":"Ben Dhifallah","year":"2010","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.autrev.2011.11.026_bb0455","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.humimm.2010.03.009","article-title":"Association between matrix metalloproteinase 9 promoter polymorphisms and Behcet's disease","volume":"71","author":"Lee","year":"2010","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0460","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/rheumatology\/kem224","article-title":"Lack of association of the \u2212463 G\/A myeloperoxidase promoter polymorphism with Behcet's disease in Italian patients","volume":"46","author":"Atzeni","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2011.11.026_bb0465","first-page":"535","article-title":"Endothelial nitric oxide synthase gene polymorphisms in Behcet's disease","volume":"29","author":"Salvarani","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0470","first-page":"185","article-title":"Glutathione S-transferase polymorphisms in patients with Behcet's disease","volume":"296","author":"Tursen","year":"2004","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.autrev.2011.11.026_bb0475","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-2230.2004.01685.x","article-title":"N-acetyltransferase 2 polymorphisms in patients with Behcet's disease","volume":"30","author":"Tamer","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0480","first-page":"1029","article-title":"Induction of Behcet's disease symptoms after dental treatment and streptococcal antigen skin test","volume":"15","author":"Mizushima","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0485","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3349\/ymj.1997.38.6.444","article-title":"Streptococcal infection in the pathogenesis of Behcet's disease and clinical effects of minocycline on the disease symptoms","volume":"38","author":"Kaneko","year":"1997","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.autrev.2011.11.026_bb0490","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/art.1780391216","article-title":"The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behcet's disease. A randomized clinical trial","volume":"39","author":"Calguneri","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.11.026_bb0495","first-page":"S32","article-title":"Association of salivary S. mutans colonisation and mannose-binding lectin deficiency with gender in Behcet's disease","volume":"27","author":"Mumcu","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0500","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1348-0421.1995.tb03249.x","article-title":"Characterization of Streptococcus sanguis isolated from patients with Behcet's disease","volume":"39","author":"Yokota","year":"1995","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0505","first-page":"1261","article-title":"Close association of Streptococcus sanguis and Behcet's disease","volume":"95","author":"Yoshikawa","year":"1991","journal-title":"Nihon Ganka Gakkai Zasshi"},{"key":"10.1016\/j.autrev.2011.11.026_bb0510","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/0-306-48382-3_36","article-title":"Detection of microbial DNA in skin lesions from patients with Behcet's disease","volume":"528","author":"Tojo","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0515","first-page":"506","article-title":"Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behcet's disease\u2014a multicenter study. The Behcet's Disease Research Committee of Japan","volume":"16","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0520","series-title":"Beh\u00e7et's disease","first-page":"133","article-title":"Experimental model for Beh\u00e7et's disease in gonotbiotic mice infected with Streptococcus sanguis","author":"Isogai","year":"2000"},{"key":"10.1016\/j.autrev.2011.11.026_bb0525","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0008-8749(92)90207-6","article-title":"Streptococcal-related antigens stimulate production of IL6 and interferon-gamma by T cells from patients with Behcet's disease","volume":"140","author":"Hirohata","year":"1992","journal-title":"Cell Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0530","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/eji.1830240712","article-title":"Fine antigen specificity of human gamma delta T cell lines (V gamma 9+) established by repetitive stimulation with a serotype (KTH-1) of a gram-positive bacterium, Streptococcus sanguis","volume":"24","author":"Mochizuki","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0535","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/0-306-48382-3_37","article-title":"Association of Mycoplasma fermentans with Adamantiades-Behcet's disease","volume":"528","author":"Zouboulis","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0540","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.3748\/wjg.v13.i21.2983","article-title":"H pylori infection in patients with Behcet's disease","volume":"13","author":"Ersoy","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0545","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00296-003-0313-4","article-title":"Seroprevalence of Borrelia burgdorferi in patients with Behcet's disease","volume":"23","author":"Onen","year":"2003","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2011.11.026_bb0550","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/00015550310007472","article-title":"Detection of herpes virus genomes in skin lesions from patients with Behcet's disease and other related inflammatory diseases","volume":"83","author":"Tojo","year":"2003","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0555","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0140-6736(82)91268-5","article-title":"Detection of RNA complementary to herpes-simplex virus in mononuclear cells from patients with Behcet's syndrome and recurrent oral ulcers","volume":"2","author":"Eglin","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2011.11.026_bb0560","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF02505221","article-title":"Polymerase chain reaction reveals herpes simplex virus DNA in saliva of patients with Behcet's disease","volume":"288","author":"Lee","year":"1996","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.autrev.2011.11.026_bb0565","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1600-0714.1996.tb01374.x","article-title":"Human cytomegalovirus as a potential etiologic agent in recurrent aphthous ulcers and Behcet's disease","volume":"25","author":"Sun","year":"1996","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.autrev.2011.11.026_bb0570","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1600-0714.1998.tb01935.x","article-title":"Preliminary evidence for an association of Epstein\u2013Barr virus with pre-ulcerative oral lesions in patients with recurrent aphthous ulcers or Behcet's disease","volume":"27","author":"Sun","year":"1998","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.autrev.2011.11.026_bb0575","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1023\/A:1022537209948","article-title":"The seroprevalence of varicella zoster antibodies in Behcet's and other skin diseases","volume":"18","author":"Akdeniz","year":"2003","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0580","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/08830189709116842","article-title":"The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behcet's disease","volume":"14","author":"Lehner","year":"1997","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0585","first-page":"21","article-title":"Behcet's disease-like symptoms induced by the Herpes simplex virus in ICR mice","volume":"8","author":"Sohn","year":"1998","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0590","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/gt.2008.180","article-title":"Interleukin-6 small interfering RNA improved the herpes simplex virus-induced systemic inflammation in vivo Behcet's disease-like mouse model","volume":"16","author":"Shim","year":"2009","journal-title":"Gene Ther"},{"key":"10.1016\/j.autrev.2011.11.026_bb0595","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1346-8138.2004.tb00703.x","article-title":"Examination of the relationship between the hepatitis C virus and Behcet's disease","volume":"31","author":"Sonmezoglu","year":"2004","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0600","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1346-8138.2005.tb00907.x","article-title":"Is there any association between hepatitis G virus (HGV), other hepatitis viruses (HBV, HCV) and Behcet's disease?","volume":"32","author":"Ozkan","year":"2005","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0605","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/rheumatology\/38.12.1279","article-title":"Prevalences of hepatitis A, B, C and E viruses in Behcet's disease","volume":"38","author":"Aksu","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2011.11.026_bb0610","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2230.2006.02330.x","article-title":"Detection of parvovirus B19 DNA in the lesional skin of patients with Behcet's disease","volume":"32","author":"Baskan","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0615","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s00018-003-2333-3","article-title":"Immunology and functional genomics of Behcet's disease","volume":"60","author":"Zierhut","year":"2003","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.autrev.2011.11.026_bb0620","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s10067-010-1491-6","article-title":"Etiopathogenesis of Behcet's disease with emphasis on the role of immunological aberrations","volume":"29","author":"Kapsimali","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0625","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.revmed.2006.02.014","article-title":"Pathophysiology of Behcet's disease","volume":"27","author":"Amoura","year":"2006","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.autrev.2011.11.026_bb0630","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1067\/mjd.2001.117728","article-title":"HSP 60 expression in mucocutaneous lesions of Behcet's disease","volume":"45","author":"Ergun","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0635","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.tripleo.2010.03.020","article-title":"HSP 60 expression in recurrent oral ulcerations of Behcet's disease","volume":"110","author":"Deniz","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.autrev.2011.11.026_bb0640","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.4049\/jimmunol.151.4.2273","article-title":"T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behcet's disease","volume":"151","author":"Pervin","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0645","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2444::AID-IMMU2444>3.0.CO;2-N","article-title":"Experimental mucosal induction of uveitis with the 60-kDa heat shock protein-derived peptide 336\u2013351","volume":"28","author":"Hu","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0650","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1006\/exer.1998.0574","article-title":"HSP-derived peptides inducing uveitis and IgG and IgA antibodies","volume":"67","author":"Uchio","year":"1998","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.autrev.2011.11.026_bb0655","first-page":"681956","article-title":"Behcet's disease (Adamantiades-Behcet's disease)","author":"Kaneko","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0660","first-page":"S44","article-title":"The role of heat shock proteins in Behcet's disease","volume":"21","author":"Direskeneli","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0665","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2249.2005.02695.x","article-title":"Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behcet's disease","volume":"139","author":"Imamura","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0670","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s004150070049","article-title":"Anti-alpha B-crystallin immunoreactivity in inflammatory nervous system diseases","volume":"247","author":"Celet","year":"2000","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0675","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/0-306-48382-3_56","article-title":"Autoimmunity to S-antigen and retinal vasculitis in patients with Behcet's disease","volume":"528","author":"Ermakova","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0680","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00417-008-0970-9","article-title":"Retinal S-antigen Th1 cell epitope mapping in patients with Behcet's disease","volume":"247","author":"Zhao","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0685","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00296-006-0281-6","article-title":"Immunopathogenesis of Behcet's disease with special emphasize on the possible role of antigen presenting cells","volume":"27","author":"Pay","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2011.11.026_bb0690","first-page":"2301","article-title":"Phenotype and functional profile of T cells expressing gamma delta receptor from patients with active Behcet's disease","volume":"21","author":"Hamzaoui","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0695","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1601-0825.2005.01185.x","article-title":"Diversity of gammadelta T cells in patients with Behcet's disease is indicative of polyclonal activation","volume":"12","author":"Freysdottir","year":"2006","journal-title":"Oral Dis"},{"key":"10.1016\/j.autrev.2011.11.026_bb0700","doi-asserted-by":"crossref","first-page":"R109","DOI":"10.1186\/ar3043","article-title":"Phenotype and functional changes of Vgamma9\/Vdelta2 T lymphocytes in Behcet's disease and the effect of infliximab on Vgamma9\/Vdelta2 T cell expansion, activation and cytotoxicity","volume":"12","author":"Accardo-Palumbo","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2011.11.026_bb0705","doi-asserted-by":"crossref","first-page":"R262","DOI":"10.1186\/ar785","article-title":"Vgamma9\/Vdelta2 T lymphocytes in Italian patients with Behcet's disease: evidence for expansion, and tumour necrosis factor receptor II and interleukin-12 receptor beta1 expression in active disease","volume":"5","author":"Triolo","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2011.11.026_bb0710","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1067\/mlc.2003.1","article-title":"Expansion of gammadelta T-cells in Behcet's disease: role of disease activity and microbial flora in oral ulcers","volume":"141","author":"Bank","year":"2003","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.autrev.2011.11.026_bb0715","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.imlet.2010.02.005","article-title":"Phenotype markers and cytokine intracellular production by CD8+ gammadelta T lymphocytes do not support a regulatory T profile in Behcet's disease patients and healthy controls","volume":"129","author":"Clemente","year":"2010","journal-title":"Immunol Lett"},{"key":"10.1016\/j.autrev.2011.11.026_bb0720","first-page":"S59","article-title":"Preferential activation of circulating CD8+ and gammadelta T cells in patients with active Behcet's disease and HLA-B51","volume":"26","author":"Yasuoka","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0725","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/0-306-48382-3_52","article-title":"Serum levels of soluble TNF-alpha receptor-II (P75), circulating gammadelta T-cells and Adamantiades-Behcet's disease activity","volume":"528","author":"Elezoglou","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0730","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/0-306-48382-3_53","article-title":"T-gammadelta receptor restriction in peripheral lymphocytes of patients with Behcet's disease","volume":"528","author":"van Hagen","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0735","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.autrev.2006.08.008","article-title":"Increased proportion of CD3+CD4-CD8\u2212 double-negative T cells in peripheral blood of children with Behcet's disease","volume":"6","author":"Ling","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.11.026_bb0740","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1136\/bjo.83.12.1386","article-title":"CD56+ T cells in the peripheral blood of uveitis patients","volume":"83","author":"Yato","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0745","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jneuroim.2006.02.011","article-title":"Discrepancies of NKT cells expression in peripheral blood and in cerebrospinal fluid from Behcet's disease","volume":"175","author":"Hamzaoui","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0750","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2249.2004.02536.x","article-title":"The number of CD8+ T cells and NKT cells increases in the aqueous humor of patients with Behcet's uveitis","volume":"137","author":"Yu","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0755","doi-asserted-by":"crossref","first-page":"6133","DOI":"10.4049\/jimmunol.175.9.6133","article-title":"CD8brightCD56+ T cells are cytotoxic effectors in patients with active Behcet's uveitis","volume":"175","author":"Ahn","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0760","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.4049\/jimmunol.161.11.5821","article-title":"Differentiation of human NK cells into NK1 and NK2 subsets","volume":"161","author":"Peritt","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0765","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1615\/CritRevImmunol.v25.i5.20","article-title":"Differentiation of NK1 and NK2 cells","volume":"25","author":"Kimura","year":"2005","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0770","first-page":"241","article-title":"The regulatory effect of natural killer cells: do \"NK-reg cells\" exist?","volume":"3","author":"Zhang","year":"2006","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0775","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/ar3005","article-title":"Natural killer cells control a T-helper 1 response in patients with Behcet's disease","volume":"12","author":"Yamaguchi","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2011.11.026_bb0780","first-page":"2299","article-title":"Increase of the natural killer activity in Behcet's disease","volume":"14","author":"Ayed","year":"1985","journal-title":"Presse Med"},{"key":"10.1016\/j.autrev.2011.11.026_bb0785","first-page":"588","article-title":"Increased peripheral blood gamma delta+ T cells and natural killer cells in Behcet's disease","volume":"19","author":"Suzuki","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0790","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1346-8138.1994.tb01729.x","article-title":"Natural cellular cytotoxicity in Behcet's disease","volume":"21","author":"Onder","year":"1994","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0795","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0002-9394(84)90711-6","article-title":"Natural killer cell activity in patients with Behcet's disease","volume":"98","author":"Watanabe","year":"1984","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0800","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2249.1990.tb05122.x","article-title":"Natural killer cell activity, interferon-gamma and antibodies to herpes viruses in patients with Behcet's disease","volume":"79","author":"Hamzaoui","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0805","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2133.1985.tb02083.x","article-title":"Natural killer cell numbers and function in peripheral lymphoid cells in Behcet's disease","volume":"113","author":"Kaneko","year":"1985","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0810","first-page":"126","article-title":"Natural killer cells in Behcet's disease","volume":"71","author":"Hamzaoui","year":"1988","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0815","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1189\/jlb.72.6.1117","article-title":"Diminution of experimental autoimmune uveoretinitis (EAU) in mice depleted of NK cells","volume":"72","author":"Kitaichi","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0820","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cyto.2008.10.007","article-title":"Interleukin-6 in neuro-Behcet's disease: association with disease subsets and long-term outcome","volume":"44","author":"Akman-Demir","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2011.11.026_bb0825","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.clineuro.2009.02.001","article-title":"CSF levels of cytokines in neuro-Behcet's disease","volume":"111","author":"Borhani Haghighi","year":"2009","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.autrev.2011.11.026_bb0830","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s004030000128","article-title":"Adamantiades-Behcet's disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells","volume":"292","author":"Zouboulis","year":"2000","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.autrev.2011.11.026_bb0835","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000018426","article-title":"Adamantiades-Behcet's disease: serum IL-8 is a more reliable marker for disease activity than C-reactive protein and erythrocyte sedimentation rate","volume":"201","author":"Katsantonis","year":"2000","journal-title":"Dermatology"},{"key":"10.1016\/j.autrev.2011.11.026_bb0840","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1365-4632.2004.02184.x","article-title":"Serum interleukin-8 as a serologic marker of activity in Behcet's disease","volume":"44","author":"Gur-Toy","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0845","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-4632.2009.03905.x","article-title":"Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement","volume":"48","author":"Durmazlar","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0850","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.imlet.2008.07.009","article-title":"Serum cytokine profiles in Behcet's disease: is there a role for IL-15 in pathogenesis?","volume":"121","author":"Curnow","year":"2008","journal-title":"Immunol Lett"},{"key":"10.1016\/j.autrev.2011.11.026_bb0855","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1365-3083.2006.01844.x","article-title":"Levels of IL-15 in serum and cerebrospinal fluid of patients with Behcet's disease","volume":"64","author":"Hamzaoui","year":"2006","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0860","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1002\/art.21145","article-title":"NF-kappaB protects Behcet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins","volume":"52","author":"Todaro","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.11.026_bb0865","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/1529-0131(199909)42:9<1967::AID-ANR24>3.0.CO;2-Z","article-title":"Th1 polarization of the immune response in Behcet's disease: a putative pathogenetic role of interleukin-12","volume":"42","author":"Frassanito","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.11.026_bb0870","first-page":"62","article-title":"Expression of cytokeratins, adhesion and activation molecules in oral ulcers of Behcet's disease","volume":"33","author":"Kose","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0875","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1468-3083.2005.01250.x","article-title":"Fas (CD95) and bcl-2 expression in active skin lesions of Behcet's disease","volume":"19","author":"Baris","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0880","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1076\/ocii.9.3.185.3961","article-title":"Disturbed expression of Fas\/FasL on CD4(+) and CD8(+)T cells in Behcet's disease, Vogt\u2013Koyanagi\u2013Harada syndrome, and idiopathic anterior uveitis","volume":"9","author":"Yang","year":"2001","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.autrev.2011.11.026_bb0885","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0021-5155(01)00469-5","article-title":"Elevated soluble Fas in aqueous humor of patients with Behcet's uveitis: correlation with uveitis severity","volume":"46","author":"Kim","year":"2002","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0890","first-page":"538","article-title":"Expression of Fas antigen (CD95) on peripheral blood lymphocytes in Behcet's disease","volume":"18","author":"Ayaslioglu","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0895","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/bjo.80.2.174","article-title":"Insufficient expression of Fas antigen on helper T cells in Behcet's disease","volume":"80","author":"Nakamura","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0900","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1076\/ocii.10.1.47.10331","article-title":"Resistance of lymphocytes to Fas-mediated apoptosis in Behcet's disease and Vogt\u2013Koyangi\u2013Harada syndrome","volume":"10","author":"Yang","year":"2002","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.autrev.2011.11.026_bb0905","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00417-007-0659-5","article-title":"Circulating neutrophils in Behcet disease is resistant for apoptotic cell death in the remission phase of uveitis","volume":"246","author":"Fujimori","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0910","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1002\/art.20334","article-title":"Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behcet's disease","volume":"50","author":"Ben Ahmed","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.11.026_bb0915","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jaut.2004.07.005","article-title":"Abnormal expression of chemokine receptors in Behcet's disease: relationship to intracellular Th1\/Th2 cytokines and to clinical manifestations","volume":"23","author":"Houman","year":"2004","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2011.11.026_bb0920","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2249.2004.02688.x","article-title":"Excessive expression of Txk, a member of the Tec family of tyrosine kinases, contributes to excessive Th1 cytokine production by T lymphocytes in patients with Behcet's disease","volume":"139","author":"Nagafuchi","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0925","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/03009740600905380","article-title":"Expression of cytokines, chemokines, and chemokine receptors in oral ulcers of patients with Behcet's disease (BD) and recurrent aphthous stomatitis is Th1-associated, although Th2-association is also observed in patients with BD","volume":"35","author":"Dalghous","year":"2006","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0930","first-page":"S16","article-title":"Imbalance of Th17 to Th1 cells in Behcet's disease","volume":"28","author":"Kim","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0935","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/0-306-48382-3_50","article-title":"Immunophenotype and Th1\/Th2 cytokines in patients with Adamantiades-Behcet's disease","volume":"528","author":"Psarra","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0940","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/rheumatology\/keh195","article-title":"Increased entry of CD4+ T cells into the Th1 cytokine effector pathway during T-cell division following stimulation in Behcet's disease","volume":"43","author":"Koarada","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2011.11.026_bb0945","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1346-8138.2003.tb00442.x","article-title":"Serum levels of IL-4, IL-10, IL-12, IL-13 and IFN-gamma in Behcet's disease","volume":"30","author":"Aridogan","year":"2003","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0950","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3121\/cmr.4.2.147","article-title":"Skewed Th1 responses caused by excessive expression of Txk, a member of the Tec family of tyrosine kinases, in patients with Behcet's disease","volume":"4","author":"Suzuki","year":"2006","journal-title":"Clin Med Res"},{"key":"10.1016\/j.autrev.2011.11.026_bb0955","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3129\/i07-179","article-title":"Th1 polarization of the immune response in uveitis in Behcet's disease","volume":"43","author":"Ilhan","year":"2008","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0960","first-page":"S27","article-title":"A Th1 but not a Th17 response is present in the gastrointestinal involvement of Behcet's disease","volume":"28","author":"Ferrante","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0965","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jaci.2011.07.008","article-title":"Regulation of T(H)17 and regulatory T cells in patients with Behcet disease","volume":"128","author":"Direskeneli","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0970","first-page":"6","article-title":"CD4+ T cells from behcet patients produce high levels of IL-17","volume":"26","author":"Chi","year":"2011","journal-title":"Yan Ke Xue Bao"},{"key":"10.1016\/j.autrev.2011.11.026_bb0975","doi-asserted-by":"crossref","first-page":"CR227","DOI":"10.12659\/MSM.881720","article-title":"Expression of Th-17 and RORgammat mRNA in Behcet's Disease","volume":"17","author":"Hamzaoui","year":"2011","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.autrev.2011.11.026_bb0980","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jneuroim.2011.01.012","article-title":"RORC and Foxp3 axis in cerebrospinal fluid of patients with neuro-Behcet's disease","volume":"233","author":"Hamzaoui","year":"2011","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0985","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/rheumatology\/keq330","article-title":"IFN-alpha blocks IL-17 production by peripheral blood mononuclear cells in Behcet's disease","volume":"50","author":"Liu","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2011.11.026_bb0990","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/icb.2010.137","article-title":"Human FoxP3(+)CD4(+) regulatory T cells: their knowns and unknowns","volume":"89","author":"Miyara","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.autrev.2011.11.026_bb0995","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1034\/j.1600-065X.2001.1820102.x","article-title":"Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance","volume":"182","author":"Sakaguchi","year":"2001","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2011.11.026_bb1000","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nri2889","article-title":"Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases","volume":"10","author":"Buckner","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1005","article-title":"Interleukin-2, interleukin-6 and T regulatory cells in peripheral blood of patients with Behcet's disease and recurrent aphthous ulcerations","author":"Pekiner","year":"2011","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.autrev.2011.11.026_bb1010","first-page":"S107","article-title":"Paradoxical high regulatory T cell activity in Behcet's disease","volume":"25","author":"Hamzaoui","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1015","first-page":"S71","article-title":"CD4+CD25+ regulatory T cells in patients with Behcet's disease","volume":"24","author":"Hamzaoui","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1020","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3109\/s10165-008-0064-x","article-title":"Decreased percentages of regulatory T cells in peripheral blood of patients with Behcet's disease before ocular attack: a possible predictive marker of ocular attack","volume":"18","author":"Nanke","year":"2008","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/ard.53.4.265","article-title":"Antibodies to endothelial cells in Behcet's disease: cell-binding heterogeneity and association with clinical activity","volume":"53","author":"Cervera","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.11.026_bb1030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/clin.1993.1059","article-title":"Antibodies to endothelial cells in patients with Behcet's disease","volume":"67","author":"Aydintug","year":"1993","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1035","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF02208085","article-title":"Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behcet's disease","volume":"14","author":"Direskeneli","year":"1995","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1040","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/art.11074","article-title":"Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behcet's disease","volume":"48","author":"Lee","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.11.026_bb1045","first-page":"S63","article-title":"Human anti-alpha-enolase antibody in sera from patients with Behcet's disease and rheumatologic disorders","volume":"27","author":"Lee","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1050","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1348-0421.2010.00215.x","article-title":"Proteomic surveillance of autoantigens in patients with Behcet's disease by a proteomic approach","volume":"54","author":"Ooka","year":"2010","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1055","first-page":"S87","article-title":"Anti-Saccharomyces cerevisiae antibodies in Behcet's disease\u2014a familial study","volume":"24","author":"Monselise","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1060","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3346\/jkms.1998.13.4.400","article-title":"Anticardiolipin and anti-beta2-glycoprotein I antibodies in Behcet's disease","volume":"13","author":"Kang","year":"1998","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.autrev.2011.11.026_bb1065","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/rheumatology\/40.2.192","article-title":"Anticardiolipin antibodies in Behcet's disease: a reassessment","volume":"40","author":"Tokay","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2011.11.026_bb1070","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/archdermatol.2008.570","article-title":"Antiphosphatidylserine-prothrombin complex antibodies in 3 patients with Behcet disease involving superficial vein thrombophlebitis","volume":"145","author":"Kawakami","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1075","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.arcmed.2005.03.019","article-title":"Lipid profile and anticardiolipin antibodies in Behcet's disease","volume":"36","author":"Musabak","year":"2005","journal-title":"Arch Med Res"},{"key":"10.1016\/j.autrev.2011.11.026_bb1080","first-page":"S104","article-title":"Increased titres of IgM anti-heparan sulfate antibody in Behcet's disease","volume":"24","author":"Briani","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1085","first-page":"S80","article-title":"Antikinectin autoantibody in Behcet's disease and several other autoimmune connective tissue diseases","volume":"25","author":"Feng","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1090","doi-asserted-by":"crossref","first-page":"R1133","DOI":"10.1186\/ar1798","article-title":"Identification of kinectin as a novel Behcet's disease autoantigen","volume":"7","author":"Lu","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2011.11.026_bb1095","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2249.2005.02760.x","article-title":"Alpha tropomyosin as a self-antigen in patients with Behcet's disease","volume":"140","author":"Mahesh","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1100","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/1521-4141(200202)32:2<356::AID-IMMU356>3.0.CO;2-9","article-title":"Identification of alpha-tropomyosin as a target self-antigen in Behcet's syndrome","volume":"32","author":"Mor","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1105","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1186\/ar1940","article-title":"Identification and characterization of the carboxy-terminal region of Sip-1, a novel autoantigen in Behcet's disease","volume":"8","author":"Delunardo","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2011.11.026_bb1110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00296-002-0274-z","article-title":"Antiannexin V autoantibody in thrombophilic Behcet's disease","volume":"24","author":"Aslan","year":"2004","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2011.11.026_bb1115","first-page":"S67","article-title":"Seroreactivity against PTEN-induced putative kinase 1 (PINK1) in Turkish patients with Behcet's disease","volume":"27","author":"Vural","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1120","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1046\/j.1365-2559.2000.00859.x","article-title":"Neutrophil and endothelial cell activation in the vasa vasorum in vasculo-Behcet disease","volume":"36","author":"Kobayashi","year":"2000","journal-title":"Histopathology"},{"key":"10.1016\/j.autrev.2011.11.026_bb1125","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2559.2004.01954.x","article-title":"Neutrophilic phlebitis is characteristic of intestinal Behcet's disease and simple ulcer syndrome","volume":"45","author":"Hayasaki","year":"2004","journal-title":"Histopathology"},{"key":"10.1016\/j.autrev.2011.11.026_bb1130","first-page":"S19","article-title":"Neutrophil activation in Behcet's disease","volume":"19","author":"Eksioglu-Demiralp","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1135","first-page":"S46","article-title":"Activation of neutrophils by testosterone in Behcet's disease","volume":"25","author":"Yavuz","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1140","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1248\/bpb.23.519","article-title":"Analysis of neutrophil proteins of patients with Behcet's disease by two-dimensional gel electrophoresis","volume":"23","author":"Yamashita","year":"2000","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.autrev.2011.11.026_bb1145","first-page":"1332","article-title":"Changes of neutrophil migration without modification of in vitro metabolism and adhesion in Behcet's disease","volume":"24","author":"Carletto","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1150","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0003-9969(90)90113-O","article-title":"Chemiluminescence of neutrophils from patients with Behcet's disease and its correlation with an increased proportion of uncommon serotypes of Streptococcus sanguis in the oral flora","volume":"35","author":"Isogai","year":"1990","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1155","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/art.1780380321","article-title":"Excessive function of peripheral blood neutrophils from patients with Behcet's disease and from HLA-B51 transgenic mice","volume":"38","author":"Takeno","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.11.026_bb1160","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/ard.48.3.206","article-title":"In vivo leucocyte migration in Behcet's syndrome","volume":"48","author":"Efthimiou","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.11.026_bb1165","first-page":"849","article-title":"Neutrophil CD64 expression in Behcet's disease","volume":"32","author":"Ureten","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1170","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s10067-009-1261-5","article-title":"Neutrophil hyperchemotaxis in Behcet's disease: a possible role for monocytes orchestrating bacterial-induced innate immune responses","volume":"28","author":"Neves","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1175","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1038\/jid.2010.114","article-title":"IL-17A has an important role in the acute attacks of Behcet's disease","volume":"130","author":"Ekinci","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1180","first-page":"247","article-title":"Auto-oxidative damage in Behcet's disease\u2013endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils","volume":"49","author":"Niwa","year":"1982","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1185","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2133.2004.06003.x","article-title":"Increased advanced oxidation protein products in Behcet's disease: a new activity marker?","volume":"151","author":"Yazici","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1190","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s10067-008-0963-4","article-title":"Evaluation of nitric oxide synthase activity, nitric oxide, and homocysteine levels in patients with active Behcet's disease","volume":"27","author":"Taysi","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1195","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1365-2133.2005.06543.x","article-title":"Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behcet's disease","volume":"153","author":"Buldanlioglu","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1200","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/0003319710382417","article-title":"Elevated oxidative stress markers and its relationship with endothelial dysfunction in Behcet disease","volume":"62","author":"Acikgoz","year":"2011","journal-title":"Angiology"},{"key":"10.1016\/j.autrev.2011.11.026_bb1205","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1346-8138.2007.00278.x","article-title":"Oxidative stress in patients with Behcet's disease: I correlation with severity and clinical parameters","volume":"34","author":"Najim","year":"2007","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1210","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1055\/s-0038-1650405","article-title":"Circulating thrombomodulin as a clue of endothelial damage in Behcet's disease","volume":"75","author":"Haznedaroglu","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.autrev.2011.11.026_bb1215","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1365-2796.1996.396853000.x","article-title":"Impaired haemostatic kinetics and endothelial function in Behcet's disease","volume":"240","author":"Haznedaroglu","year":"1996","journal-title":"J Intern Med"},{"key":"10.1016\/j.autrev.2011.11.026_bb1220","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF01451044","article-title":"Thrombomodulin levels in Behcet's disease with and without the factor V Leiden mutation","volume":"17","author":"Gurgey","year":"1998","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1225","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1006\/clim.1999.4687","article-title":"Enhancement of endothelial cell E-selectin expression by sera from patients with active Behcet's disease: moderate correlation with anti-endothelial cell antibodies and serum myeloperoxidase levels","volume":"91","author":"Triolo","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1230","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10067-004-0982-8","article-title":"Levels of soluble E-selectin in patients with active Behcet's disease","volume":"24","author":"Sari","year":"2005","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1235","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/0-306-48382-3_55","article-title":"L-selectin expression on leukocytes of patients with Behcet's disease","volume":"528","author":"Assaad-Khalil","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1240","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/147323000203000113","article-title":"Serum E-selectin and beta 2-microglobulin levels in Behcet's disease","volume":"30","author":"Karakuzu","year":"2002","journal-title":"J Int Med Res"},{"key":"10.1016\/j.autrev.2011.11.026_bb1245","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10067-006-0512-y","article-title":"Serum-soluble selectin levels in patients with Behcet's disease","volume":"26","author":"Ates","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1250","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1055\/s-0038-1646409","article-title":"Coagulation and fibrinolytic activity in Behcet's disease","volume":"66","author":"Hampton","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.autrev.2011.11.026_bb1255","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1007\/s10067-006-0449-1","article-title":"Endothelial functions are more severely impaired during active disease period in patients with Behcet's disease","volume":"26","author":"Caliskan","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1260","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1742-1241.2005.00477.x","article-title":"Impaired endothelium-dependent flow-mediated dilation in Behcet's disease: more prominent endothelial dysfunction in patients with vascular involvement","volume":"59","author":"Oflaz","year":"2005","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.autrev.2011.11.026_bb1265","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0735-1097(00)01137-2","article-title":"Vascular endothelial function and oxidative stress mechanisms in patients with Behcet's syndrome","volume":"37","author":"Chambers","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1270","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.amjcard.2004.04.073","article-title":"Vascular endothelial function and plasma homocysteine levels in Behcet's disease","volume":"94","author":"Ozdemir","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1275","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1515\/CCLM.2007.018","article-title":"Assessment of homocysteine, neopterin and nitric oxide levels in Behcet's disease","volume":"45","author":"Ozkan","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.autrev.2011.11.026_bb1280","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.thromres.2006.02.008","article-title":"Decreased nitric oxide and increased platelet aggregation levels in patients with Behcet's disease","volume":"119","author":"Yapislar","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.autrev.2011.11.026_bb1285","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000018061","article-title":"Decreased nitric oxide production in patients with Behcet's disease","volume":"198","author":"Orem","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.autrev.2011.11.026_bb1290","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1067\/mjd.2002.118338","article-title":"Increased nitric oxide production in patients with Behcet's disease: is it a new activity marker?","volume":"46","author":"Evereklioglu","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1295","first-page":"S25","article-title":"Interactions of nitric oxide and superoxide dismutase in Behcet's disease","volume":"19","author":"Kiraz","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1300","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000040847","article-title":"Haemostasis, thrombosis, and endothelium in Behcet's disease","volume":"99","author":"Haznedaroglu","year":"1998","journal-title":"Acta Haematol"},{"issue":"Suppl 1","key":"10.1016\/j.autrev.2011.11.026_bb1305","first-page":"S53","article-title":"The lumps and bumps of Behcet's syndrome","volume":"3","author":"Yazici","year":"2004","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.11.026_bb1310","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/ard.60.12.1081","article-title":"Behcet's disease and thrombophilia","volume":"60","author":"Leiba","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.11.026_bb1315","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1136\/ard.2003.014241","article-title":"Thrombophilic factors are not the leading cause of thrombosis in Behcet's disease","volume":"63","author":"Leiba","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.11.026_bb1320","first-page":"2196","article-title":"Association of factor V Leiden with Behcet's disease","volume":"24","author":"Mammo","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1325","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0002-9394(99)00184-1","article-title":"Factor V Leiden mutation is associated with ocular involvement in Behcet disease","volume":"128","author":"Verity","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1330","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0002-9343(01)01048-8","article-title":"Vascular involvement in Behcet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin","volume":"112","author":"Espinosa","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2011.11.026_bb1335","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1161\/ATVBAHA.110.207068","article-title":"Homocysteine in vascular Behcet disease: a meta-analysis","volume":"30","author":"La Regina","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1340","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/rheumatology\/40.6.687","article-title":"Hyperhomocysteinaemia in Behcet's disease","volume":"40","author":"Aksu","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2011.11.026_bb1345","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1515\/CCLM.2008.046","article-title":"Relationship between thiolactonase activity and hyperhomocysteinemia according to MTHFR gene polymorphism in Tunisian Behcet's disease patients","volume":"46","author":"Koubaa","year":"2008","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.autrev.2011.11.026_bb1350","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/bjo.86.6.653","article-title":"Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behcet's disease","volume":"86","author":"Er","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1355","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/ard.48.7.590","article-title":"Defective fibrinolysis in Behcet's syndrome: significance and possible mechanisms","volume":"48","author":"Aitchison","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.11.026_bb1360","first-page":"S53","article-title":"Fibrinolytic activity and d-dimer levels in Behcet's syndrome","volume":"23","author":"Yurdakul","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1365","first-page":"83","article-title":"Erythrocyte deformability does not seem to be altered in Behcet's disease","volume":"36","author":"Simo","year":"2007","journal-title":"Clin Hemorheol Microcirc"},{"key":"10.1016\/j.autrev.2011.11.026_bb1370","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-4632.2009.04229.x","article-title":"Reduced erythrocyte deformability in active and untreated Behcet's disease patients","volume":"49","author":"Tatlican","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1375","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/1076029606293430","article-title":"Circulated activated platelets and increased platelet reactivity in patients with Behcet's disease","volume":"12","author":"Akar","year":"2006","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.autrev.2011.11.026_bb1380","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/0-306-48382-3_38","article-title":"Antimicrobial activity of synthetic human CAP18 peptides to Streptococcus sanguis isolated from patients with Behcet's disease","volume":"528","author":"Isogai","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1385","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1128\/IAI.59.4.1434-1441.1991","article-title":"Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Behcet's syndrome","volume":"59","author":"Lehner","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.autrev.2011.11.026_bb1390","first-page":"255","article-title":"Cytokine production of peripheral blood mononuclear cells stimulated with Streptococcus sanguis antigen in patients with Behcet's disease","volume":"528","author":"Lee","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1395","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1574-695X.2006.00135.x","article-title":"Regarding neutrophil and lymphocyte responses to oral Streptococcus in Adamantiades-Behcet's disease","volume":"47","author":"Evereklioglu","year":"2006","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1400","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/0-306-48382-3_35","article-title":"The role of infectious agents in the pathogenesis of Behcet's disease","volume":"528","author":"Kaneko","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1405","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1086\/319681","article-title":"Expression of Th2 cytokines decreases the development of and improves Behcet's disease-like symptoms induced by herpes simplex virus in mice","volume":"183","author":"Sohn","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2011.11.026_bb1410","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1365-2249.1997.3611265.x","article-title":"Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behcet's disease (BD) in Japan","volume":"108","author":"Kaneko","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1415","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2133.2006.07536.x","article-title":"The role of heat shock protein 60, vascular endothelial growth factor and antiphospholipid antibodies in Behcet disease","volume":"156","author":"Shaker","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2011.11.026_bb1420","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1128\/CMR.12.1.19","article-title":"Role of heat shock proteins in protection from and pathogenesis of infectious diseases","volume":"12","author":"Zugel","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.autrev.2011.11.026_bb1425","first-page":"S96","article-title":"Serum levels of free heat shock protein 70 and anti-HSP70 are elevated in Behcet's disease","volume":"26","author":"Birtas-Atesoglu","year":"2008","journal-title":"Clin Exp Rheumatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211003004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211003004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T14:38:37Z","timestamp":1686494317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997211003004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":285,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S1568997211003004"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2011.11.026","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}